Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
BeiGene, Ltd. | 10%+ Owner | American Depositary Shares | 18,943,802 | $3.42 B | $180.50 | Sep 10, 2021 | Direct |
Neumora Therapeutics, Inc. | 10%+ Owner | Common Stock | 35,368,653 | $424 M | $11.98 | Sep 19, 2023 | Direct |
Vigil Neuroscience, Inc. | 10%+ Owner | Common Stock | 3,206,281 | $12 M | $3.75 | Jan 11, 2022 | Direct |
Neumora Therapeutics, Inc. | 10%+ Owner | Series A-2 Preferred Stock | 0 | Sep 19, 2023 | Direct | ||
Neumora Therapeutics, Inc. | 10%+ Owner | Series B Preferred Stock | 0 | Sep 19, 2023 | Direct | ||
Vigil Neuroscience, Inc. | 10%+ Owner | Series A Preferred Stock | 0 | Jan 11, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NMRA | Neumora Therapeutics, Inc. | Sep 19, 2023 | 4 | 29,999,985 | 4 | Sep 19, 2023 | 10%+ Owner |
NMRA | Neumora Therapeutics, Inc. | Sep 14, 2023 | 0 | 0 | 3 | Sep 14, 2023 | 10%+ Owner |
VIGL | Vigil Neuroscience, Inc. | Jan 11, 2022 | 2 | 0 | 4 | Jan 11, 2022 | 10%+ Owner |
VIGL | Vigil Neuroscience, Inc. | Jan 6, 2022 | 0 | 0 | 3 | Jan 6, 2022 | 10%+ Owner |
BGNE | BeiGene, Ltd. | Sep 10, 2021 | 1 | 49,999,938 | 4 | Sep 13, 2021 | 10%+ Owner |